Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China
· Delayed Price · Currency is CNY 34.17
-1.18 (-3.34%)
Apr 29, 2026, 3:04 PM CST
SHE:002940 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 6,701 | 6,574 | 2,632 | 4,377 | 3,684 | 3,486 | Upgrade
|
| Market Cap Growth | 144.03% | 149.74% | -39.86% | 18.80% | 5.68% | -12.16% | Upgrade
|
| Enterprise Value | 6,600 | 6,484 | 2,582 | 4,255 | 3,430 | 2,877 | Upgrade
|
| Last Close Price | 34.17 | 33.52 | 13.11 | 21.30 | 18.11 | 16.64 | Upgrade
|
| PE Ratio | 55.11 | 52.40 | 32.77 | 31.63 | 28.94 | 29.09 | Upgrade
|
| PS Ratio | 4.70 | 4.61 | 1.74 | 2.70 | 2.35 | 2.53 | Upgrade
|
| PB Ratio | 3.59 | 3.52 | 1.46 | 2.39 | 2.24 | 2.36 | Upgrade
|
| P/TBV Ratio | 5.63 | 5.52 | 2.43 | 3.86 | 2.56 | 2.73 | Upgrade
|
| P/FCF Ratio | 34.51 | 33.85 | 16.54 | 28.80 | 31.78 | 31.59 | Upgrade
|
| P/OCF Ratio | 27.45 | 26.93 | 10.38 | 15.81 | 19.94 | 17.64 | Upgrade
|
| EV/Sales Ratio | 4.63 | 4.55 | 1.71 | 2.63 | 2.19 | 2.08 | Upgrade
|
| EV/EBITDA Ratio | 23.56 | 23.15 | 12.58 | 17.65 | 16.91 | 14.56 | Upgrade
|
| EV/EBIT Ratio | 32.50 | 31.93 | 21.81 | 26.00 | 24.19 | 19.02 | Upgrade
|
| EV/FCF Ratio | 33.99 | 33.39 | 16.23 | 28.00 | 29.59 | 26.07 | Upgrade
|
| Debt / Equity Ratio | 0.24 | 0.24 | 0.27 | 0.32 | 0.21 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 1.60 | 1.60 | 2.37 | 2.43 | 1.71 | 0.01 | Upgrade
|
| Debt / FCF Ratio | 2.31 | 2.31 | 3.06 | 3.88 | 2.99 | 0.02 | Upgrade
|
| Net Debt / Equity Ratio | -0.18 | -0.18 | -0.14 | -0.15 | -0.28 | -0.51 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.22 | -1.22 | -1.20 | -1.16 | -2.26 | -3.78 | Upgrade
|
| Net Debt / FCF Ratio | -1.75 | -1.75 | -1.55 | -1.84 | -3.95 | -6.77 | Upgrade
|
| Asset Turnover | 0.48 | 0.48 | 0.51 | 0.58 | 0.67 | 0.69 | Upgrade
|
| Inventory Turnover | 1.81 | 1.81 | 2.06 | 2.66 | 2.28 | 1.74 | Upgrade
|
| Quick Ratio | 1.24 | 1.24 | 1.16 | 1.55 | 1.40 | 1.79 | Upgrade
|
| Current Ratio | 1.83 | 1.83 | 1.78 | 2.13 | 1.84 | 2.31 | Upgrade
|
| Return on Equity (ROE) | 8.55% | 8.55% | 8.37% | 10.53% | 8.46% | 9.91% | Upgrade
|
| Return on Assets (ROA) | 4.28% | 4.28% | 2.47% | 3.64% | 3.79% | 4.70% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.65% | 11.47% | 7.31% | 10.55% | 13.29% | 19.59% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.50% | 9.50% | 5.60% | 7.20% | 7.80% | 10.20% | Upgrade
|
| Earnings Yield | 1.87% | 1.91% | 3.05% | 3.16% | 3.46% | 3.44% | Upgrade
|
| FCF Yield | 2.90% | 2.95% | 6.05% | 3.47% | 3.15% | 3.16% | Upgrade
|
| Dividend Yield | 0.57% | - | 0.95% | 0.99% | 1.14% | 0.86% | Upgrade
|
| Payout Ratio | 45.92% | 45.92% | 73.15% | 44.53% | 26.83% | 39.27% | Upgrade
|
| Buyback Yield / Dilution | -0.74% | -0.74% | -0.15% | -0.82% | 0.42% | -5.03% | Upgrade
|
| Total Shareholder Return | -0.18% | -0.74% | 0.81% | 0.16% | 1.56% | -4.17% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.